Lujiazui, the core financial area of Pudong, has now gathered around 8,000 financial institutions. Approximately 80 percent ...

UBS has received regulatory approval to fully own Beijing-headquartered UBS Securities, the Swiss bank said on Friday, ...

Shanghai Henlius Biotech, Inc. (2696.HK) and Organon today announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for HLX11, an investigational ...

The Notes will be general unsecured obligations of the Company and bear interest at a rate of 0.50% per year, payable semiannually in arrears on April 1 and October 1 of each year, beginning on ...

Wu Qing, head of the China Securities Regulatory Commission, emphasized that DeepSeek's success has not only impressed the ...

Beijing is quietly stepping up its backing of the Chinese stock market and has pledged stronger credit support for the tech sector, signaling a more hands-on approach to steering the economy through a ...

Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today published its annual ESG report for 2024. The report ...

As we settle into a new year, the global initial public offering landscape presents a fascinating tapestry of challenges and ...

This landmark agreement between MOL/MOLCT, and CMB.TECH involves nine ammonia-powered ships. Three ammonia-fitted 210.000 dwt ...

Beijing, 12th March 2025 – UBS announces that the firm has received the approval from the China Securities Regulatory Commission (CSRC) to retain a 14.99% stake in Credit Suisse Securities (China) ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (“NDA”) for TAZVERIK® (tazemetostat) has been granted conditional approval in China for the treatment of ...